In Rio de Janeiro, Finance Minister Nirmala Sitharaman engaged in high-level talks with Brics counterparts from Russia, China, Brazil, and Indonesia, reinforcing India’s dedication to collaboration. Discussions spanned financial cooperation, the New Development Bank, and global growth strategies.
India is actively negotiating bilateral investment treaties with over a dozen nations to protect and promote investments, aiming to become a global manufacturing hub. These agreements offer broader investor protections enforceable by international arbitration. The goal is to rebuild India’s BIT ecosystem on modernised terms, balancing investor confidence and domestic policy space.
China has retaliated against the EU by banning European companies from bidding on large medical equipment contracts, escalating trade tensions. This action follows the EU’s restrictions on Chinese firms in medical device procurements, citing unfair practices.
CII president Rajiv Memani emphasizes that India needs 10% average nominal GDP growth annually to realize its Viksit Bharat vision by 2047. He anticipates the India-US interim trade pact will reduce uncertainty, fostering technology transfers and partnerships. CII projects India’s economic growth between 6.4% and 6.7% this fiscal year, driven by strong domestic demand.
Public sector banks are gearing up to recruit approximately 50,000 personnel this financial year, including 21,000 officer-level positions, to expand operations and enhance customer service. State Bank of India will lead the hiring spree, onboarding around 20,000 individuals. While facing short-term margin pressures, the sector anticipates healthy earnings growth between FY25 and FY27.
Indian equity markets brace for a volatile week as the US tariff suspension deadline looms, impacting sectors like IT and pharma. Investors await the outcome of India-US trade negotiations and the release of US FOMC minutes. Corporate earnings, led by TCS and Avenue Supermarts, will also shape market sentiment.
India’s pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry’s…
India’s pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry’s…
Indian Railways is considering reducing or eliminating ‘clerkage’ fees deducted from cancelled waitlisted tickets, potentially benefiting passengers. This move comes as online bookings increase and operational costs decrease. Simultaneously, Railways will require identity verification for Tatkal bookings starting July 1, 2025, using Aadhaar or DigiLocker.
Nitin Gadkari envisions a transformative shift in India’s transport sector, emphasizing electric mass transit, hyperloop systems, and ropeway connectivity. The government is actively pursuing innovative mobility solutions to curb pollution, enhance connectivity, and lower logistics expenses. Furthermore, initiatives include expanding highways, adopting green energy, and promoting flex-fuel vehicles to reduce reliance on fossil fuels and…
